Actemra 400 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DB25FZS51
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,084
Award facts
- Contract value 100% obligated
- $7,084.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,084.36 by the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Actemra 400 mg/20 ml vials. This firm fixed-price delivery order is not associated with a set-aside designation and carries an ultimate completion date of August 25, 2025. The award represents a single line item delivery under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA, which carries a total ceiling value of approximately $500 million through November 2026 and enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure multiple contract vehicles with the DLA. The company's contract portfolio demonstrates consistent delivery of branded and generic prescription medications, biologics, and medical consumables to Department of Defense healthcare sites nationwide. This particular delivery order for Actemra, a biologic immunosuppressant medication, reflects the company's ongoing role in distributing specialty pharmaceuticals and injectable therapies essential to military medical operations and beneficiary care.
Quick answers
Who was awarded contract SPE2DB25FZS51?
SPE2DB25FZS51 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FZS51 worth?
The government has obligated $7,084 on SPE2DB25FZS51.
Is contract SPE2DB25FZS51 an order under another contract?
Yes. SPE2DB25FZS51 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS51 competed?
The extent of competition for SPE2DB25FZS51 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award